Assessing Genomic Sequencing Information for Health Care Decision Making

Rapid advances in technology have lowered the cost of sequencing an individual’s genome from the several billion dollars that it cost a decade ago to just a few thousand dollars today and have correspondingly greatly expanded the use of genomic information in medicine. Because of the lack of evidence available for assessing variants, evaluation bodies have made only a few recommendations for the use of genetic tests in health care. For example, organizations, such as the Evaluation of Genomic Applications in Practice and Prevention working group, have sought to set standards for the kinds of evaluations needed to make population-level health decisions. However, due to insufficient evidence, it has been challenging to recommend the use of a genetic test. An additional challenge to using large-scale sequencing in the clinic is that it may uncover “secondary,” or “incidental,” findings – genetic variants that have been associated with a disease but that are not necessarily related to the conditions that led to the decision to use genomic testing. Furthermore, as more genetic variants are associated with diseases, new information becomes available about genomic tests performed previously, which raises issues about how and whether to return this information to physicians and patients and also about who is responsible for the information.
To help develop a better understanding of how genomic information is used for healthcare decision making, the Roundtable on Translating Genomic-Based Research for Health of the Institute of Medicine held a workshop in Washington,DC in February 2014. Stakeholders, including clinicians, researchers, patients, and government officials, discussed the issues related to the use of genomic information in medical practice. Assessing Genomic Sequencing Information for Health Care Decision Making is the summary of that workshop. This report compares and contrasts evidence evaluation processes for different clinical indications and discusses key challenges in the evidence evaluation process.

Download Now
Read Online

Here is Download Link

Assessing Genomic Sequencing Information For Health Care Decision Making


Assessing Genomic Sequencing Information For Health Care Decision Making Download Now

Read Online

Author by : Institute of Medicine
Languange Used : en
Release Date : 2014-08-19
Publisher by : National Academies Press






Clinical Genome Sequencing


Clinical Genome Sequencing Download Now

Read Online

Author by : Aad Tibben
Languange Used : en
Release Date : 2019-03-30
Publisher by : Academic Press






The Economics Of Genomic Medicine


The Economics Of Genomic Medicine Download Now

Read Online

Author by : Institute of Medicine
Languange Used : en
Release Date : 2013-06-20
Publisher by : National Academies Press






Using Nursing Research To Shape Health Policy


Using Nursing Research To Shape Health Policy Download Now

Read Online

Author by : Patricia A. Grady, PhD, RN, FAAN
Languange Used : en
Release Date : 2017-03-15
Publisher by : Springer Publishing Company






Biomarker Tests For Molecularly Targeted Therapies


Biomarker Tests For Molecularly Targeted Therapies Download Now

Read Online

Author by : National Academies of Sciences, Engineering, and Medicine
Languange Used : en
Release Date : 2016-06-30
Publisher by : National Academies Press






Advances In Oncology Nursing An Issue Of Nursing Clinics


Advances In Oncology Nursing An Issue Of Nursing Clinics Download Now

Read Online

Author by : Margaret Barton-Burke
Languange Used : en
Release Date : 2017-02-17
Publisher by : Elsevier Health Sciences






Economic Evaluation In Genomic Medicine


Economic Evaluation In Genomic Medicine Download Now

Read Online

Author by : Vasilios Fragoulakis
Languange Used : en
Release Date : 2015-03-20
Publisher by : Academic Press






Leave a Reply

Your email address will not be published. Required fields are marked *